IgG-RFT5-dgA
Term · Oncology and biomedicine · MLC-T-ONC-004147
A monoclonal antibody linked to a toxic substance. It is being studied in the treatment of melanoma that has spread to distant parts of the body. IgG-RFT5-dgA is made in the laboratory. It can find and kill certain white blood cells that prevent the immune system from killing cancer cells. Also called RFT5-dgA immunotoxin.
| Identifier | MLC-T-ONC-004147 |
|---|---|
| Field | Oncology and biomedicine |
| Expansions | RFT5-dgA immunotoxin |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-004147",
"term": "IgG-RFT5-dgA",
"field": "Oncology and biomedicine",
"definition": "A monoclonal antibody linked to a toxic substance. It is being studied in the treatment of melanoma that has spread to distant parts of the body. IgG-RFT5-dgA is made in the laboratory. It can find and kill certain white blood cells that prevent the immune system from killing cancer cells. Also called RFT5-dgA immunotoxin.",
"expansions": [
"RFT5-dgA immunotoxin"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/igg-rft5-dga/"
}
Record 8,974 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.